Cargando…

Which trial do we need? Management of elderly, fragile, fully vaccinated patients hospitalized for SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Trøseid, Marius, Arribas, Jose R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834114/ https://www.ncbi.nlm.nih.gov/pubmed/36641054 http://dx.doi.org/10.1016/j.cmi.2023.01.006

Ejemplares similares

Why we may need to rethink future SARS-CoV-2 vaccination strategies
por: Klimek, Peter
Publicado: (2021)

Do we still need supertrees?
por: Haeseler, Arndt von
Publicado: (2012)

In a search of a protective titer: Do we or do we not need to know?
por: Baranova, Ancha, et al.
Publicado: (2021)

How do we best relax control measures as vaccine coverage for SARS-CoV-2 rises?
por: Foy, Brody H, et al.
Publicado: (2021)

We need people’s WHO to solve vaccine inequity, and we need it now
por: Kim, Hani
Publicado: (2021)

Why do we need improved mobility technology?
por: Boninger, Michael L, et al.
Publicado: (2012)

Why Do We Need To Diversify the Microbial Sciences?
por: Torres, Alfredo G.
Publicado: (2021)

Advance care planning; we need to do it more, but it needs to be done differently
por: Heyland, Daren K.
Publicado: (2020)

Skin rashes after SARS‐CoV‐2 vaccine: which relationship, if any?
por: Patruno, Cataldo, et al.
Publicado: (2021)

Trial management: we need a cadre of high-class triallists to deliver the answers that patients need
por: Beaumont, Danielle, et al.
Publicado: (2019)

Do we really need another risk prediction rule? Yes, we do
por: Lo, Alexander X., et al.
Publicado: (2022)

Inotropes in goal-directed therapy: Do we need 'goals'?
por: Futier, Emmanuel, et al.
Publicado: (2010)

Do we really need standards in digital image management?
por: Ho, ELM
Publicado: (2008)

Can we do for other essential medicines what we are doing for the COVID-19 vaccine?
por: Murphy, Adrianna, et al.
Publicado: (2021)

Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data
por: Díaz, Natalia A., et al.
Publicado: (2021)

Do we need an assessment of the nutrition risk in the critically ill patient?
por: Preiser, Jean-Charles
Publicado: (2012)

Do we need new trials of procalcitonin-guided antibiotic therapy?
por: Lisboa, Thiago, et al.
Publicado: (2018)

Why do we need better omics in the breast cancer care?
por: Gertych, Arkadiusz, et al.
Publicado: (2021)

What do we still need to learn on digitally assessed biomarkers?
por: Acs, Balazs, et al.
Publicado: (2021)

Why do we need male contraceptives?
por: Cheng, C Yan, et al.
Publicado: (2013)

If the treatment works, do we need to know why?: the promise of immunotherapy for experimental medicine
por: Ehrenstein, Michael R., et al.
Publicado: (2007)

Do we need a 6D’s Framework of Nutritional Stewardship in critical care?
por: Pisani, Dafne, et al.
Publicado: (2021)

Commentary: Extracorporeal membrane oxygenation for patients with refractory Coronavirus Disease 2019 (COVID-19): What do we know and what do we need to learn?
por: Jacobs, Jeffrey P., et al.
Publicado: (2022)

Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009)

Liquid gold: do we need to fraction fresh colostrum for oral immunotherapy in premature infants?
por: Pillai, Anish, et al.
Publicado: (2022)

Commentary: Do we really need specific recommendations for the use of one-piece hybrid devices?
por: Preventza, Ourania, et al.
Publicado: (2020)

Transvenous Lead Extraction: Do We Need to Explore Alternative Techniques?
por: Ellis, Christopher R.
Publicado: (2019)

Cryoballoon ablation: Do we still need real-time recordings?
por: Bisignani, Antonio, et al.
Publicado: (2021)

Which amount of fluid do we need to evaluate preload dependency?
por: Marc, J, et al.
Publicado: (2015)

Do we need clinical trials to test the ability of transdermal HRT to prevent coronary heart disease?
por: Crook, David
Publicado: (2001)

Combination therapies in Myeloproliferative Neoplasms: why do we need them and how to identify potential winners?
por: McLornan, Donal, et al.
Publicado: (2013)

Do we need sequential local therapy following neoadjuvant chemotherapy for locally advanced pancreatic cancer?
por: Kleeff, Jörg, et al.
Publicado: (2019)

Do We Really Need Expensive Stent-Grafts to Treat External Iliac Artery Lesions Effectively?
por: Öcal, Osman, et al.
Publicado: (2023)

World Health Organization AWaRe framework for antibiotic stewardship: Where are we now and where do we need to go? An expert viewpoint
por: Mudenda, Steward, et al.
Publicado: (2023)

Commentary: Is this a case in which we know what we don't know what we don't know?
por: Nantsios, Alex, et al.
Publicado: (2021)

Pregnant adolescents living with HIV: what we know, what we need to know, where we need to go
por: Callahan, Tegan, et al.
Publicado: (2017)

Do we care asthma?
por: Jindal, S.K.
Publicado: (2012)

Why we still need drugs for COVID‐19 and can't just rely on vaccines
por: Robinson, Bruce W. S., et al.
Publicado: (2021)

Do asymptomatic carriers of SARS-COV-2 transmit the virus?
por: Muller, Claude P.
Publicado: (2021)

Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?
por: Bauer, Lisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cgk81gs86h8lqikm6pd2o1fdlo